Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- 31 May 2009
- journal article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 30 (5), 682-690
- https://doi.org/10.1016/j.neurobiolaging.2007.08.010
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- No association of CSF biomarkers with APOE 4, plaque and tangle burden in definite Alzheimer's diseaseBrain, 2007
- Prediction of Alzheimer’s Disease Using the CSF Aβ42/Aβ40 Ratio in Patients with Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyThe Lancet Neurology, 2006
- Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tauNeurobiology of Aging, 2004
- CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective StudyExperimental Neurology, 2000
- Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's diseaseAnnals of Neurology, 1998
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Alz‐50 Antibody recognizes alzheimer‐related neuronal changesAnnals of Neurology, 1988
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984